Andrea Morotti

Country flagItaly

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (8)

Year:

2026

Introduction The efficacy of endovascular treatment (EVT) in ischemic stroke patients with distal-medium vessel occlusion (DMVO) remains unclear. We evaluated whether CT-perfusion target mismatch criteria (TMC) could predict functional independence in patients with M2 non- or codominant middle cerebral artery DMVO. Materials and methods This retrospective study analyzed consecutive patients with M2 DMVO receiving EVT and imaged with multimodal CT study protocol within 24 h from onset. A receiver operating characteristic curve analysis was used to identify the infarct core volume cutoff to predict functional independence (modified Rankin Scale 0–2 at 3-months). This parameter was subsequently considered as part of TMC together with penumbra volume ⩾ 10 mL and mismatch ratio ⩾1.2. The association between TMC and functional independence was tested with logistic regression. Results A total of 115 patients with M2 were included. Infarct core volume had good discriminative ability for functional independence (AUC 0.75; 95%CI 0.64–0.84) and the best cut-off value was ⩽30 mL (77% sensitivity, 61% specificity, 69% positive predictive value, 70% negative predictive value). TMC were independently associated with functional independence (OR [odds ratio] = 6.50, 95%CI = 2.37–17.77, p < 0.001), excellent outcome (modified Rankin scale 0–1 at 3-months, OR = 3.28, 95%CI = 1.30–8.31, p = 0.012) and final infarct volume (B = −35.52, p = 0.004). After including interaction terms, a significant treatment effect on functional independence was observed between successful recanalization and TMC (OR = 3.82, 95%CI = 1.64–8.89, p = 0.002). Discussion and conclusion In patients with M2 non- or codominant DMVO receiving EVT, TMC identified as core volume ⩽30 mL, penumbra volume ⩾ 10 mL, and mismatch ratio ⩾ 1.2, were associated with better functional outcome. Our findings suggest that functional independence after EVT was not directly related to successful recanalization, which is indeed effective only in patients with a favorable baseline imaging profile, including a small infarct core size, and in the presence of small penumbra volumes.

Year:

2026

Background: CT perfusion (CTP) overestimation of core volume >10 mL compared to the final infarct volume (FIV) size is the current definition of the ghost infarct core (GIC) phenomenon. However, subsequent infarct growth might influence FIV. We aimed to report a more reliable assessment of GIC occurrence, defined as no evidence of infarct at 24 h follow-up imaging, compared to CTP core volume at admission. This phenomenon was named absolute GIC (aGIC), and we investigated its prevalence and predictors. Methods: A total of 652 consecutive stroke patients with large vessel occlusion who achieved successful recanalization (mTICI 2b-3) after endovascular treatment (EVT) and non-contrast CT (NCCT) follow-up imaging at 24 h were retrospectively analyzed. Ischemic core volume was automatically generated from CTP, and FIV was manually determined on follow-up NCCT. Multivariable logistic regression was used to explore aGIC predictors. Results: We included 652 patients (53.3% female, median age 75 years), of whom 35 (5.3%) had an aGIC. The aGIC group showed higher ASPECTS (p < 0.001), shorter (<3 h) onset-to-imaging time (p < 0.016), poorer collaterals (p < 0.001), and higher hypoperfusion intensity ratio (p < 0.001) compared to the non-aGIC group. In multivariate analysis, ASPECTS (odds ratio (OR), 2.37; p <0.001), onset-to-imaging time (OR, 0.99; p = 0.034), collateral score (OR, 0.24; p < 0.001), and hypoperfusion intensity ratio (OR, 23.2; p < 0.001) were independently associated with aGIC. Conclusions: aGIC is a more reliable evaluation of infarct core volume overestimation assessed on admission CTP and represents a rare phenomenon, associated with ultra-early presentation and poor collaterals.

Year:

2025

Background Given the increasing diversity among neurological patients, standardized protocols are essential for evaluating the severity and complexity of the variety of conditions. Aim of the present work was to standardize the assessment of the severity and complexity of neurological impairment in an acute setting by using a modified version of the Neurological Impairment Scale (mNIS). Methods consecutively hospitalized neurological inpatients underwent a multidimensional standardized assessment of multimorbidity, frailty, functional dependency, and neurological impairment using mNIS and other validated scales. Inter-rater reliability of the mNIS total and sub-scores was evaluated. Construct validity was assessed separately in patients with Cerebrovascular disease performing correlations between corresponding sub-scores of mNIS, original NIS, and National Institutes of Health Stroke Scale (NIHSS). mNIS Complexity Index (mNIS-CI) for neurological severity was used to classify patients into subtle, mild, moderate, and severe impairment. Results one thousand eighty-one neurological patients admitted to a neurological ward from the emergency setting were enrolled. The inter-rater reliability was remarkable for mNIS total and sub-scores (ICC 0.90, 95% CI 0.82–0.95). The mNIS showed strong construct validity for total and sub-scores compared to other clinical scales (r 0.47-0.97, p<0.001) and 52.7% of patients scored at least one in one of the four newly listed items. The stratification of patients according to mNIS-CI exhibited high construct validity distinguishing the extent of impairment and involved domains. Conclusions The mNIS is valuable for measuring neurologic severity and complexity in acute inpatients and holds significant potential for application in different settings. What is already known on this topic Standardization of neurological assessment and development of functional rating scales of global impairment are pivotal to characterize and follow up patients both in the clinical practice and in the research setting. What this study adds mNIS is a valuable tool to measure neurologic severity and complexity in acute inpatients: the four added items are useful for capturing a broader spectrum of signs and symptoms; the severity and complexity scores provide different information about neurological status and domain imapired at individual level. How this study might affect research, practice, or policy mNIS can be instrumental in grading the severity of neurological conditions, tracking clinical progress, and gauging response to treatments in the acute setting.

Year:

2025

Purpose To develop and evaluate an automated segmentation and classification tool for the discrimination of neoplastic and non-neoplastic intracerebral hemorrhage (ICH) on admission Computed Tomography (CT) utilizing images containing hemorrhage and perihematomal edema. Materials and Methods The models were developed and evaluated using a retrospective dataset of patients who presented with acute ICH of unknown cause upon admission, using CT scans obtained from a single institution between January 2016 and May 2020 for both training and testing. Etiology of ICH were binarized into non-neoplastic and neoplastic ICH according to follow-up MRI results based on the ATOMIC ICH classification. Masks for ICH and PHE were manually segmented. Two separate models were trained: 1) An nnU-Net segmentation model 2) A ResNet-34 classification model. An end-to-end tool was evaluated by concatenating the two models which allowed the segmentation model to preprocess the images for the classification model. Performance enhancement was assessed by fine-tuning the model on a randomly selected, small subset of the external cohort. To assess the model’s generalizability, the performance was additionally validated on an external dataset. Evaluation metrics were accuracy (Acc), area under the curve (AUC) and corresponding sensitivities and specificities. Results A total of 291 patients were included of whom 116 (39.86%) presented with neoplastic and 175 (60.14%) with non-neoplastic ICH. The end-to-end classification tool achieved an Acc of 86% and an AUC of 85% with a sensitivity and specificity of 80% and 93% in the test set. On the external validation cohort (n=58), the classification pipeline achieved an AUC of 68% and Acc of 66% (sensitivity 64%; specificity 67%). Fine-tuning on a selected small subset of the external cohort enhanced performance, achieving an AUC and accuracy of 70% (sensitivity 70%; specificity 71%). Conclusion An end-to-end classification tool achieved a high diagnostic performance and generalizability in classifying neoplastic from non-neoplastic ICH on CT, suggesting a robust framework for a potential clinical implementation as a decision-aided tool in early ICH management.

Year:

2024

Background CT-Perfusion (CTP) overestimation of core volume >10 mL compared to the final infarct volume (FIV) size is the current definition of the ghost infarct core (GIC) phenomenon. However, subsequent infarct growth might influence FIV. We aimed to report a more reliable assessment of GIC occurrence, defined as the lack of FIV at 24 hours follow-up imaging, compared to CTP core volume at admission. This phenomenon was named absolute GIC (aGIC) and we investigated its prevalence and predictors. Methods A total of 652 consecutive stroke patients with large vessel occlusion who achieved successful recanalization (mTICI 2b-3) after Endovascular Treatment (EVT) and non-contrast CT (NCCT) follow-up imaging at 24 hours were retrospectively analyzed. Ischemic core volume was automatically generated from CTP, and FIV was manually determined on follow-up NCCT. Multivariable logistic regression was used to explore aGIC predictors. Results We included 652 patients (53.3% female, median age 75 years), of whom 35 (5.3%) had an aGIC. The aGIC group showed higher ASPECTS (p<0.001), shorter (<3 hours) onset-to-imaging time (p<0.001), poorer collaterals (p<0.001), higher hypoperfusion intensity ratio (p=0.001) compared to the non-aGIC group. In multivariate analysis, ASPECTS (odds ratio [OR], 1.87; p<0.001), onset-to-imaging time (OR, 0.99; p=0.013), collateral score (OR, 0.45; p<0.004) and hypoperfusion intensity ratio (OR, 23.2; p<0.001) were independently associated with aGIC. Conclusion aGIC is a more reliable evaluation of infarct core volume overestimation assessed on admission CTP and represents a rare phenomenon, associated with ultra-early presentation and poor collaterals.

Year:

2024

Background The efficacy and safety of statins for secondary prevention in patients who have experienced a cardioembolic stroke are not well-defined. However, previous observational data reported hyperlipidemia as a risk factor for both ischemic and bleeding complications in patients with AF and previous stroke. Based on these premises, we conducted a sub-analysis of the RAF and RAF-NOAC studies to evaluate the efficacy and safety of statins in secondary prevention in patients with acute ischemic stroke and AF. Methods We combined patient data from the RAF and RAF-NOAC studies, prospective observational studies conducted across Stroke Units in Europe, the United States, and Asia from January 2012 to June 2016. We included consecutive patients with AF who suffered an acute ischemic stroke with a follow-up of 90 days. Our outcomes were the combined endpoint, including stroke, transient ischemic attack, systemic embolism, symptomatic intracerebral hemorrhage, and major extracranial bleeding. Furthermore, both ischemic and hemorrhagic outcomes were evaluated separately. Results A total of 1.742 patients were included (46% male), and 898 (52%) received statins after the index event. At multivariable analysis, statin use was statistically associated with age (OR 0.92, 95% CI 0.97 - 0.99, p = 0.001), male sex (OR 1.35, 95% CI 1.07 - 1.70, p = 0.013), anticoagulation (OR 2.53, 95% CI 1.90 - 3.36, p <0.0001), hyperlipidemia (OR 5.52, 95% CI 4.28 - 7.12, p <0.0001), paroxysmal AF (OR 1.40, 95% CI 1.12 - 1.75, p = 0.003), leukoaraiosis (OR 1.39, 95% CI 1.11 - 1.75, p = 0.004) and heart failure (OR 0.72, 95% CI 0.53 - 0.98, p = 0.034). Statin use was not associated with the combined outcome event (OR 0,81, 95% CI 0,56 – 1,19, p = 0.286) and ischemic outcome event (OR 1,13, 95% CI 0,71 – 1,82, p = 0.604) while was associated with a lower risk of hemorrhagic outcome event (OR 0,49, 95% CI 0,27 – 0,88, p = 0.016). Conclusions Our data show that statins seem to protect against global bleeding events in cardioembolic stroke patients; this may be due to the pleiotropic effect of statins. More data are warranted to confirm these findings.

Year:

2024

Objective The objective of this paper was to explore the utility of time to maximum concentration (T max )‐based target mismatch on computed tomography perfusion (CTP) in predicting radiological and clinical outcomes in patients with acute ischemic stroke (AIS) with anterior circulation large vessel occlusion (LVO) selected for endovascular treatment (EVT). Methods Patients with AIS underwent CTP within 24 hours from onset followed by EVT. Critically hypoperfused tissue and ischemic core volumes were automatically calculated using T max thresholds >9.5 seconds and >16 seconds, respectively. The difference between T max > 9.5 seconds and T max > 16 seconds volumes and the ratio between T max > 9.5 seconds and T max > 16 seconds volumes were considered ischemic penumbra and T max mismatch ratio, respectively. Final infarct volume (FIV) was measured on follow‐up non‐contrast computed tomography (CT) at 24 hours. Favorable clinical outcome was defined as 90‐day modified Rankin Scale 0 to 2. Predictors of FIV and outcome were assessed with multivariable logistic regression. Optimal T max volumes for identification of good outcome was defined using receiver operating curves. Results A total of 393 patients were included, of whom 298 (75.8%) achieved successful recanalization and 258 (65.5%) achieved good outcome. In multivariable analyses, all T max parameters were independent predictors of FIV and outcome. T max > 16 seconds volume had the strongest association with FIV (beta coefficient = 0.596 p <0.001) and good outcome (odds ratio [OR] = 0.96 per 1 ml increase, 95% confidence interval [CI] = 0.95–0.97, p < 0.001). T max > 16 seconds volume had the highest discriminative ability for good outcome (area under the curve [AUC] = 0.88, 95% CI = 0.842–0.909). A T max > 16 seconds volume of ≤67 ml best identified subjects with favorable outcome (sensitivity = 0.91 and specificity = 0.73). Interpretation T max target mismatch predicts radiological and clinical outcomes in patients with AIS with LVO receiving EVT within 24 hours from onset. ANN NEUROL 2022;91:878–888

Year:

2022

Collaborators (46)

Simona Sacco

Full Professor of Neurology - Head of the Clinical Neurology Unit

University of L'Aquila

ITALY
View details

Danilo Toni

Full Professor of Neurology

Sapienza University

ITALY
View details

Alessandro Pezzini

Associate Professor of Neurology

University of Parma

ITALY
View details

Walter Ageno

Associate Professor

University of Insubria

ITALY
View details

Davide Strambo

-

SWITZERLAND
View details

Umberto Pensato

IRCCS Humanitas Research Hospital

ITALY
View details

George Ntaios

Professor of Internal Medicine

University of Thessaly

GREECE
View details

Giacomo Urbinati

University of Bologna

ITALY
View details

Sung Il Sohn

Professor

Keimyung University Dongsan Medical Center

SOUTH KOREA
View details

Theodoros Karapanayiotides

Associate Professor

Aristotle University of Thessaloniki

GREECE
View details

Georgios Tsivgoulis

-

UNITED STATES
View details

Piergiorgio Lochner

Head of Neurointensive Care Unit Unit and Neurosonology Lab

Saarland University

GERMANY
View details

Patrik Michel

Associate Professor

Lausanne University Hospital

SWITZERLAND
View details

Stefano Forlivesi

IRCCS Istituto Delle Scienze Neurologiche di Bologna

ITALY
View details

Anna Poggesi

University of Florence

ITALY
View details

Eugenia Rota

Chief

-

ITALY
View details

Jukka Putaala

-

FINLAND
View details

Maria Kosmidou

Ass Professor

Aristotle University of Thessaloniki

GREECE
View details

Uta Hanning

University Medical Center Hamburg-Eppendorf

GERMANY
View details

Brian Mac Grory

Assistant Professor

Duke University School of Medicine

UNITED STATES
View details

Azmil H Abdul-Rahim

University of Glasgow

UNITED KINGDOM
View details

Gian Marco De Marchis

Head of Personal Board

University Hospital Basel

SWITZERLAND
View details

MARINA DIOMEDI

Associate Professor, Tor Vergata University

University of Rome Tor Vergata

ITALY
View details

Laetitia Yperzeele

Antwerp University Hospital

BELGIUM
View details

Leonardo Pantoni

-

ITALY
View details

Stefan Engelter

Chair Department Rehabilitation & Neurology and Head of Stroke Treatment Pathyway

-

SWITZERLAND
View details

Sotirios Giannopoulos

Professor fo Neurology

National and Kapodistrian University of Athens

GREECE
View details

Lina Palaiodimou

National and Kapodistrian University of Athens

GREECE
View details

Jesse Dawson

Professor of Stroke Medicine

University of Glasgow

UNITED KINGDOM
View details

Yuriy Flomin

Professor

ukraine; shupyk national healthcare university of ukraine

UKRAINE
View details

Turgut Tatlisumak

Professor

Göteborgs Universitet

SWEDEN
View details

Isabella Canavero

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY
View details

Daniel Strbian

-

FINLAND
View details

Andrea Dell'Orco

Charité - Universitätsmedizin Berlin

GERMANY
View details

Andrea Pilotto

Associate Professor in Neurology

University of Brescia

ITALY
View details

PANAGIOTIS HALVATSIOTIS

Associate Professor

National and Kapodistrian University of Athens - Faculty of Medicine

GREECE
View details

Federico Mazzacane

Neurologist

Fondazione Istituto Neurologico Nazionale Casimiro Mondino

ITALY
View details

Maurizio Paciaroni

Docenti di ruolo di IIa fascia

University of Ferrara

ITALY
View details

Konstantinos Vadikolias

Professor

Democritus University of Thrace

GREECE
View details

Maurizio Acampa

University of Siena

ITALY
View details

PIERLUIGI BERTORA

Assistant professor

Università degli Studi di Torino

ITALY
View details

Jawed Nawabi

Charité - Universitätsmedizin Berlin

GERMANY
View details

David Seiffge

-

SWITZERLAND
View details

Francesco Arba

University of Florence

ITALY
View details

Alexandros Polymeris

Attending Neurologist

University Hospital Basel

SWITZERLAND
View details

Manuel Cappellari

-

ITALY
View details